Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05630170 · ClinicalTrials.gov registry record · NA
The SMART-LV Pilot Study
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05630170: Completed NA study, sponsored by Yale University.
NCT05630170 is a NA study that has completed, run by Yale University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05630170, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this pilot study is to evaluate the prospective performance of an image-based, smartphone-adaptable artificial intelligence electrocardiogram (AI-ECG) strategy to predict and detect left ventricular systolic dysfunction (LVSD) in a real-world setting.
Primary Outcome
Device feasibility of AI-ECG will be evaluated by comparing the proportion of patients with LVSD on echocardiography among those with a high predicted probability of LVSD on an AI-ECG screen compared with the proportion of patients with LVSD on echocardiography in those with a negative AI-ECG screen. Higher proportions indicate successful detection of asymptomatic LVSD compared with routine clinical care.
Interventions
- DEVICE AI-ECG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-09-13 |
| Est. Completion | 2024-05-22 |
| Phase | NA |
What the finished NCT05630170 record still lists
NCT05630170 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which AI-ECG is the first listed.
NCT05630170 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05630170 about?
NCT05630170 is a clinical study titled "The SMART-LV Pilot Study". The goal of this pilot study is to evaluate the prospective performance of an image-based, smartphone-adaptable artificial intelligence electrocardiogram (AI-ECG) strategy to predict and detect left ventricular systolic dysfunction (LVSD) in a real-world setting.
What is the current status of trial NCT05630170?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-09-13. Estimated completion is 2024-05-22.
What interventions are being tested in trial NCT05630170?
The interventions under investigation include: AI-ECG (DEVICE).
Who is sponsoring clinical trial NCT05630170?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05630170's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI